[3+2] Route to Quaternary Oxaprolinol Derivatives
MW), from 7c (145 mg, 0.63 mmol) as an oil, yield 208 mg MW), from 7c (135 mg, 0.58 mmol) as an oil, yield 103 mg
(0.35 mmol, 55%); Rf 0.18 (hexane/THF, 7:3, UV and vanilline vi-
sualization); [α]2D0 = +8.35 (c = 2.24, CH2Cl2). 1H NMR (400 MHz,
CDCl3, 25 °C): δ = 7.75 (d, J = 7.6 Hz, 2 H), 7.54 (dd, J = 5.9,
(0.19 mmol, 32%); Rf 0.32 (hexane/THF, 7:3, UV and vanilline vi-
1
sualization); [α]2D0 = –3.28 (c = 3.9, CH2Cl2). H NMR (400 MHz,
CDCl3, 25 °C): δ = 7.76 (d, J = 7.5 Hz, 2 H), 7.61 (d, J = 7.6 Hz,
6.5 Hz, 2 H), 7.38 (t, J = 7.6 Hz, 2 H), 7.32–7.12 (m, 7 H), 5.52 2 H), 7.39 (t, J = 7.6 Hz, 2 H), 7.31 (t, J = 7.6 Hz, 2 H), 5.51 (d, J
(dd, J = 0.3, 5.5 Hz, 1 H), 5.52 (d, J = 8.6 Hz, 1 H), 4.98 (ddd, J = 9.4 Hz, 1 H), 5.48 (dd, J = 2.5, 5.6 Hz, 1 H), 4.62 (dd, J = 4.5,
= 4.7, 7.4, 8.6 Hz, 1 H), 4.46 (d, J = 11.2 Hz, 1 H), 4.38 (dd, J = 9.4 Hz, 1 H), 4.52 (d, J = 11.3 Hz, 1 H), 4.41 (dd, J = 7.4, 10.1 Hz,
10.1, 13.4 Hz, 1 H), 4.24 (d, J = 11.2 Hz, 1 H), 4.15 (dd, J = 7.7,
13.4 Hz, 1 H), 4.15 (dd, J = 7.7, 10.1 Hz, 1 H), 3.16 (dd, J = 4.8,
13.8 Hz, 1 H), 2.87 (dd, J = 7.4, 13.8 Hz, 1 H), 2.58 (dd, J = 5.5,
1 H), 4.30 (dd, J = 7.0, 10.1 Hz, 1 H), 4.26 (d, J = 11.3 Hz, 1 H),
4.24 (dd, J = 7.0, 7.4 Hz, 1 H), 2.58 (dd, J = 5.6, 12.7 Hz, 1 H),
2.05 (dd, J = 2.5, 12.7 Hz, 1 H), 2.30–2.22 (m, 1 H), 2.01 (s, 3 H),
12.7 Hz, 1 H), 2.08 (s, 3 H), 2.06 (dd, J = 0.3, 12.7 Hz, 1 H), 1.70 1.63 (s, 3 H), 1.27 (s, 9 H), 1.01 (d, J = 6.9 Hz, 3 H), 0.90 (d, J =
(s, 3 H), 1.31 (s, 9 H) ppm. 13C NMR (100 MHz, CDCl3, 25 °C): δ 6.9 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3, 25 °C): δ = 170.5,
= 170.5, 166.0, 155.5, 144.0, 143.9, 141.3 (2 C), 136.5, 129.6 (2CH),
128.3 (2CH), 127.6 (2CH), 127.0 (2CH), 126.8 (CH), 125.2 (2CH),
166.7, 156.5, 144.0 (2 C), 141.3 (2 C), 127.6 (2CH), 127.0 (2CH),
125.2 (2CH), 119.9 (2CH), 96.7 (CH), 76.0, 66.9 (CH2), 65.9 (CH2),
119.9 (2CH), 96.8 (CH), 76.0, 66.8 (CH2), 65.8 (CH2), 63.5, 53.3 63.3, 56.7 (CH), 47.2 (CH), 45.9 (CH2), 30.5 (CH), 28.6 (3CH3),
(CH), 47.1 (CH), 45.7 (CH2), 38.1 (CH2), 28.6 (3CH3), 21.5 (CH3), 21.3 (CH ), 20.7 (CH ), 19.8 (CH ), 16.5 (CH ) ppm. IR (neat): ν
˜
3
3
3
3
20.8 (CH ) ppm. IR (neat): ν = 2976, 1724, 1640, 1451, 1242, = 2972, 1743, 1639, 1450, 1238, 1057 cm–1. HRMS (ESI): m/z
˜
3
1054 cm–1. HRMS (ESI): m/z calcd. for C35H41N2O7 [M + H]+ calcd. for C31H41N2O7 [M + H]+ 553.2908; found 553.2885; calcd.
601.2908; found 601.2901; calcd. for C35H40N2NaO7 [M + Na]+ for C31H40N2NaO7 [M + Na]+ 575.2728; found 575.2715.
623.2728; found 623.2727.
(3S,5S)-5-tert-Butoxy-2-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonyl-
amino)-2-phenylacetyl]-3-methylisoxazolidin-3-ylmethyl Acetate
(8d): Obtained according to the general procedure (70 °C, 30 min,
MW), from 7c (80 mg, 0.35 mmol) as an oil, yield 100 mg
9H-Fluoren-9-ylmethyl (2S)-2-[(3S,5S)-3-(Acetoxymethyl)-5-tert-
butoxy-3-methylisoxazolidin-2-ylcarbonyl]pyrrolidine-1-carboxylate
(8b): Obtained according to the general procedure (70 °C, 30 min,
MW), from 7c (80 mg, 0.34 mmol) as an oil, yield 95 mg
(0.17 mmol, 49%); 80:20 diastereomer ratio; Rf 0.47 (hexane/THF,
(0.17 mmol, 50%); Rf 0.23 (hexane/THF, 7:3, UV and vanilline vi-
1
7:3, UV and vanilline visualization). H NMR (400 MHz, CDCl3,
sualization); [α]2D0 = +2.91 (c = 0.94, CH2Cl2). This compound is a
25 °C): δ (major diastereoisomer) = 7.74 (d, J = 7.6 Hz, 2 H), 7.54
mixture of two rotamers in a 60:40 ratio. 1H NMR (400 MHz,
(dd, J = 5.9, 6.5 Hz, 1 H), 7.38 (t, J = 7.6 Hz, 2 H), 7.32–7.12 (m,
CDCl3, 25 °C): δ (major rotamer) = 7.75 (d, J = 7.2 Hz, 2 H), 7.61
7 H), 6.24 (d, J = 8.0 Hz, 1 H), 5.66 (d, J = 8.0 Hz, 1 H), 5.37 (dd,
(dd, J = 3.1, 7.2 Hz, 2 H), 7.39 (d, J = 7.2 Hz, 2 H), 7.30 (td, J =
J = 1.0, 5.5 Hz, 1 H), 4.55 (d, J = 11.2 Hz, 1 H), 4.32 (m, 2 H),
1.6, 7.2 Hz, 2 H), 5.47 (dd, J = 1.0, 5.4 Hz, 1 H), 4.74 (dd, J = 2.1,
4.18 (t, J = 7.2 Hz, 1 H), 4.08 (d, J = 11.2 Hz, 1 H), 2.47 (dd, J =
8.6 Hz, 1 H), 4.52 (d, J = 11.0 Hz, 1 H), 4.42 (dd, J = 7.5, 10.3 Hz,
5.5, 12.7 Hz, 1 H), 2.00 (dd, J = 1.0, 12.7 Hz, 1 H), 1.76 (s, 3 H),
1 H), 4.29 (dd, J = 7.1, 7.4 Hz, 1 H), 4.22 (d, J = 11.0 Hz, 1 H),
1.71 (s, 3 H), 1.31 (s, 9 H) ppm. δ (characteristic signals of minor
4.19 (dd, J = 7.1, 10.3 Hz, 1 H), 3.73 (m, 1 H), 3.56 (m, 1 H), 2.52
diastereoisomer) = 5.99 (d, J = 8.8 Hz, 1 H), 5.76 (d, J = 8.6 Hz,
(dd, J = 5.4, 10.7 Hz, 1 H), 2.06 (s, 3 H), 2.2–1.9 (m, 4 H), 1.98
1 H), 5.40 (dd, J = 1.7, 5.6 Hz, 1 H), 4.63 (d, J = 11.0 Hz, 1 H),
(dd, J = 1.0, 10.7 Hz, 1 H), 1.69 (s, 3 H), 1.31 (s, 9 H) ppm; δ
2.55 (dd, J = 5.4, 12.5 Hz, 1 H) ppm. 13C NMR (100 MHz, CDCl3,
(minor rotamer) = 7.74 (dd, J = 2.6, 7.2 Hz, 2 H), 7.66 (dd, J =
25 °C): δ (major diastereoisomer) = 170.3, 164.1, 155.2, 144.0,
4.1, 7.2 Hz, 2 H), 7.36 (dd, J = 2.6, 7.2 Hz, 2 H), 7.29 (dt, J = 1.6,
143.9, 141.2 (2 C), 138.2, 128.5 (2CH), 127.9 (CH), 127.8 (2CH),
7.2 Hz, 2 H), 5.49 (dd, J = 1.5, 5.5 Hz, 1 H), 4.81 (dd, J = 2.6,
127.6 (2CH), 127.0 (2CH), 125.3 (CH), 125.2 (CH), 119.9 (2CH),
8.8 Hz, 1 H), 4.55 (d, J = 11.0 Hz, 1 H), 4.42 (dd, J = 7.5, 10.3 Hz,
96.7 (CH), 75.9, 67.0 (CH2), 64.9 (CH2), 63.4, 56.2 (CH), 47.1
1 H), 4.29 (dd, J = 7.1, 7.4 Hz, 1 H), 4.28 (d, J = 11.0 Hz, 1 H),
(CH), 45.4 (CH2), 28.7 (3CH3), 21.4 (CH3), 20.4 (CH3) ppm. δ
4.19 (dd, J = 7.1, 10.3 Hz, 1 H), 3.73 (m, 1 H), 3.56 (m, 1 H), 2.55
(characteristic signals of minor diastereoisomer) = 170.6, 164.6,
(dd, J = 5.5, 10.7 Hz, 1 H), 2.07 (s, 3 H), 2.2–1.9 (m, 4 H), 2.03
155.6, 75.8, 67.9 (CH2), 65.7 (CH2), 63.6, 55.7 (CH) ppm. IR
(dd, J = 1.5, 10.7 Hz, 1 H), 1.71 (s, 3 H), 1.19 (s, 9 H) ppm. 1H
(neat): ν = 2976, 1744, 1639, 1450, 1238 cm–1. HRMS (DCI, NH ):
˜
3
NMR (400 MHz, CDCl3, 60 °C): δ (characteristic signals) = 7.75
(d, J = 7.2 Hz, 2 H), 7.66 (d, J = 7.2 Hz, 1 H), 7.61 (d, J = 7.2 Hz,
1 H), 7.39 (d, J = 7.2 Hz, 2 H), 7.30 (d, J = 7.2 Hz, 2 H), 5.47 (m,
1 H), 4.78 (m, 1 H), 4.55–4.15 (m, 5 H), 2.52 (m, 1 H) ppm. 13C
NMR (100 MHz, CDCl3, 25 °C): δ (major rotamer) = 170.4, 167.4,
154.9, 144.5, 144.0, 141.3, 141.1, 127.3 (2CH), 127.1 (2CH), 125.6
(2CH), 125.5 (2CH), 96.4 (CH), 75.7, 67.3 (CH2), 65.7 (CH2), 63.2,
58.8 (CH), 47.3 (CH), 46.8 (CH2), 45.8 (CH2), 34.2 (CH2), 28.6
(3CH3), 22.7 (CH2), 21.7 (CH3), 20.8 (CH3) ppm; δ (minor rot-
amer) = 170.3, 167.1, 154.8, 144.4, 144.3, 141.2, 135.8, 127.0
(2CH), 126.9 (2CH), 125.4 (2CH), 125.3 (2CH), 96.6 (CH), 75.6,
68.0 (CH2), 65.5 (CH2), 63.3, 58.7 (CH), 47.5 (CH), 47.4 (CH2),
45.9 (CH2), 34.3 (CH2), 28.7 (3CH3), 22.6 (CH2), 22.0 (CH3), 20.8
m/z calcd. for C34H38N2O7 [M + H+] 587.2757; found 587.2745.
(3S,5S)-5-tert-Butoxy-2-[(2S)-2-(1,3-dioxo-1,3-dihydroisoindol-2-
yl)-3-methylbutyryl]-3-methylisoxazolidin-3-ylmethyl Acetate (8e):
Obtained according to the general procedure (110 °C, 60 min,
MW), from 7c (12 mg, 0.052 mmol) as an oil in an inseparable
60:40 mixture with remaining phthalyl valine (19 mg, 0.030 mmol
8e, estimated yield 58%). Rf 0.45 (cyclohexane/EtOAc, 1:1, UV and
vanilline visualization). 1H NMR (400 MHz, CDCl3, 25 °C): δ =
7.85 (dd, J = 3.2, 5.4 Hz, 2 H), 7.70 (dd, J = 2.9, 5.4 Hz, 2 H), 5.44
(dd, J = 2.0, 5.4 Hz, 1 H), 4.86 (d, J = 10.0 Hz, 1 H), 4.59 (d, J =
11.2 Hz, 1 H), 4.27 (d, J = 11.2 Hz, 1 H), 3.03 (m, 1 H), 2.51 (dd,
J = 5.4, 12.5 Hz, 1 H), 2.06 (s, 3 H), 1.97 (dd, J = 2.0, 12.7 Hz,
1 H), 1.59 (s, 3 H), 1.17 (s, 9 H), 1.11 (d, J = 6.8 Hz, 3 H), 0.93 (d,
J = 6.6 Hz, 3 H) ppm. 13C NMR (100 MHz, CDCl3, 25 °C): δ =
170.5, 168.0, 163.2, 133.9 (CH), 131.9, 123.4 (CH), 96.6 (CH), 75.8,
65.5 (CH2), 63.6, 58.1 (CH), 45.5 (CH2), 28.3 (3CH3), 27.5 (CH),
(CH ) ppm. IR (neat): ν = 2976, 1745, 1707, 1655, 1418, 1239 cm–1.
˜
3
HRMS (ESI): m/z calcd. for C31H38N2O7 [M + H]+ 551.2752;
found 551.2723; calcd. for C31H37N2NaO7 [M + Na]+ 573.2571;
found 573.2555.
(3S,5S)-5-tert-Butoxy-2-[(2S)-2-(9H-fluoren-9-ylmethoxycarbonyl- 21.4 (CH ), 20.8 (CH ), 19.9, 19.8 (2CH ) ppm. IR (neat): ν =
˜
3
3
3
amino)-3-methylbutyryl]-3-methylisoxazolidin-3-ylmethyl Acetate
(8c): Obtained according to the general procedure (70 °C, 30 min,
2973, 1743, 1638, 1450, 1238, 1056 cm–1. HRMS (DCI, NH3): m/z
calcd. for C24H32N2O7 [M + H+] 461.2288; found 461.2294.
Eur. J. Org. Chem. 2015, 3923–3934
© 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
3931